bimatoprost vehicle solution

DRUG5 trials

Sponsors

Allergan

Conditions

AlopeciaAlopecia, AndrogeneticBaldnessEyelash HypotrichosisHypotrichosis

Phase 2

Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia

CompletedNCT01325337

AllerganAlopecia, Alopecia, Androgenetic, Baldness

Start: 2011-06-30End: 2012-09-30Updated: 2014-04-10

Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss

CompletedNCT01325350

AllerganAlopecia, Baldness

Start: 2011-06-30End: 2012-09-30Updated: 2014-04-09

Phase 3

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis

CompletedNCT01391286

AllerganEyelash Hypotrichosis

Start: 2011-07-01End: 2012-05-25Updated: 2019-07-08

Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

CompletedNCT01391273

AllerganEyelash Hypotrichosis

Start: 2011-07-01End: 2012-05-19Updated: 2019-07-08

Phase 4

Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence

CompletedNCT01448525

AllerganHypotrichosis

Start: 2011-10-31End: 2012-04-30Updated: 2013-05-22